Medical Weight Loss for Bloomington, Indiana Residents

Bloomington, Indiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Bloomington through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Flexible payment for Bloomington residents: we accept HSA, FSA, Klarna, and Affirm, so paying for your Indiana telehealth program can fit your budget. Medication is billed separately. Doctor review just $119 (medication separate).

Why Bloomington Residents Choose New Hope Weight Loss

New Hope keeps the money part simple so you can focus on the health part. For Bloomington patients that means semaglutide from $166 monthly, tirzepatide from $233 monthly, a $119 physician visit, no insurance required, and no penalty for living outside Costa Mesa. We take HSA, FSA, Klarna, and Affirm, so paying out of pocket does not have to mean paying all at once. Clear terms, no games.

Medical weight loss for Bloomington is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

People throughout Bloomington reach the same physician-supervised care that built our reputation in Costa Mesa, and they do it from home, because telehealth erases the gap between Indiana and California. We care for patients throughout Downtown, the university area, and the greater south-central Indiana region. Your semaglutide or tirzepatide travels in insulated cold-pack packaging to keep it stable on the way to Bloomington, even on warm Indiana afternoons.

Tirzepatide from $233 per month and semaglutide from $166 per month cost the same whether you are in downtown Bloomington or a rural corner of Indiana. Getting started in Bloomington is simple: a Indiana licensed physician reviews your health history for $119, and your medication is billed separately if you are approved. New Hope Weight Loss treats patients throughout Indiana entirely by telehealth from our Costa Mesa, California clinic, so the same physician care comes to you wherever you live in the state.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Bloomington telehealth patients.

How Telehealth Works for Bloomington

No waiting rooms, no commute across Bloomington traffic. Everything happens online. You answer a focused intake quiz about your goals and medical background, Dr. Anjmun Sharma reviews it and sees you by secure video (usually within 48 hours), and if a compounded GLP-1 is appropriate she sends the prescription to a state-licensed 503(a) pharmacy. That pharmacy ships your semaglutide or tirzepatide to your Bloomington home in cold-pack packaging that keeps it cool the whole way. Follow-up visits are by video as well, so dose adjustments and questions are handled from wherever you are in .

Frequently Asked Questions, Bloomington

Where is the closest New Hope Weight Loss to Bloomington?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Bloomington, Indiana patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from Bloomington?

It is not. We run a complete telehealth model, so people in Bloomington handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to Bloomington using cold-pack insulation that keeps it stable until it reaches you.

What should a Bloomington patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Bloomington patients are not charged any extra distance fee.

What areas of Bloomington do you serve?

We serve patients from across Bloomington by telehealth, including Downtown, the university area, and the greater south-central Indiana region.

Is my health information private as a Bloomington patient?

Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Bloomington patients get the same confidentiality as any telehealth patient.

Bloomington Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Bloomington, Indiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.